Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial
Year: 2012
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Neurology
Authors: Michael S Okun, Bruno V Gallo, George Mandybur, Jonathan Jagid, Kelly D Foote, Fredy J Revilla, Ron Alterman, Joseph Jankovic, Richard Simpson, Fred Junn, Leo Verhagen, Jeff E Arle, Blair Ford, Robert R Goodman, R Malcolm Stewart, Stacy Horn, Gordon H Baltuch, Brian H Kopell, Frederick Marshall, DeLea Peichel, Rajesh Pahwa, Kelly E Lyons, Alexander I Tröster, Jerrold L Vitek, Michele Tagliati
Institutions: University of Florida Health, University of Florida, University of Miami, University of Cincinnati, University of Cincinnati Medical Center, Icahn School of Medicine at Mount Sinai, Baylor College of Medicine, Houston Methodist, Beaumont Hospital, Dearborn, Rush University Medical Center, Lahey Hospital and Medical Center, Columbia University Irving Medical Center, Texas Health Dallas, Pennsylvania Hospital, University of Pennsylvania Health System, Medical College of Wisconsin, University of Rochester Medicine, University of Rochester, University of Kansas Medical Center, University of North Carolina at Chapel Hill, University of Minnesota, Cedars-Sinai Medical Center
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: U.S. Department of Veterans Affairs, National Parkinson Foundation, GlaxoSmithKline, Medtronic, Batten Disease Support and Research Association, Teva Pharmaceutical Industries, Parkinson Alliance, Parkinson Study Group, Merz Pharmaceuticals, National Institutes of Health, U.S. Food and Drug Administration, St. Jude Medical, Allergan, Allos Therapeutics, National Institute of Neurological Disorders and Stroke
OpenAlex ID: W2117902019